Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer (E5103)

PURPOSE: Bevacizumab improves progression-free survival but not overall survival in patients with metastatic breast cancer. E5103 tested the effect of bevacizumab in the adjuvant setting in patients with human epidermal growth factor receptor 2–negative disease. PATIENTS AND METHODS: Patients were a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Oncol
Main Authors: Miller, Kathy D., O’Neill, Anne, Gradishar, William, Hobday, Timothy J., Goldstein, Lori J., Mayer, Ingrid A., Bloom, Stuart, Brufsky, Adam M., Tevaarwerk, Amye J., Sparano, Joseph A., Le-Lindqwister, Nguyet Anh, Hendricks, Carolyn B., Northfelt, Donald W., Dang, Chau T., Sledge, George W.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2018
Fag:
ORIGINAL REPORTS
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6118403/
https://ncbi.nlm.nih.gov/pubmed/30040523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2018.79.2028
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker